nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—SLC6A3—Parkinson's disease	0.325	0.382	CbGaD
Fluvoxamine—CYP2E1—Parkinson's disease	0.232	0.273	CbGaD
Fluvoxamine—CYP2D6—Parkinson's disease	0.171	0.201	CbGaD
Fluvoxamine—ABCB1—Parkinson's disease	0.122	0.143	CbGaD
Fluvoxamine—SLC6A3—telencephalic ventricle—Parkinson's disease	0.00227	0.109	CbGeAlD
Fluvoxamine—SLC6A3—nerve—Parkinson's disease	0.00143	0.0688	CbGeAlD
Fluvoxamine—SLC6A3—hindbrain—Parkinson's disease	0.00107	0.0515	CbGeAlD
Fluvoxamine—SLC6A4—hindbrain—Parkinson's disease	0.00098	0.0472	CbGeAlD
Fluvoxamine—SLC6A3—brainstem—Parkinson's disease	0.000613	0.0295	CbGeAlD
Fluvoxamine—SLC6A3—forebrain—Parkinson's disease	0.000592	0.0285	CbGeAlD
Fluvoxamine—SLC6A4—brainstem—Parkinson's disease	0.000562	0.027	CbGeAlD
Fluvoxamine—SLC6A4—forebrain—Parkinson's disease	0.000542	0.0261	CbGeAlD
Fluvoxamine—CYP2D6—hindbrain—Parkinson's disease	0.000473	0.0227	CbGeAlD
Fluvoxamine—SLC6A3—midbrain—Parkinson's disease	0.000391	0.0188	CbGeAlD
Fluvoxamine—SIGMAR1—medulla oblongata—Parkinson's disease	0.000389	0.0187	CbGeAlD
Fluvoxamine—SLC6A3—spinal cord—Parkinson's disease	0.000381	0.0184	CbGeAlD
Fluvoxamine—SLC6A4—midbrain—Parkinson's disease	0.000358	0.0172	CbGeAlD
Fluvoxamine—SIGMAR1—midbrain—Parkinson's disease	0.000356	0.0171	CbGeAlD
Fluvoxamine—SLC6A4—spinal cord—Parkinson's disease	0.000349	0.0168	CbGeAlD
Fluvoxamine—SIGMAR1—spinal cord—Parkinson's disease	0.000347	0.0167	CbGeAlD
Fluvoxamine—SLC6A3—head—Parkinson's disease	0.000339	0.0163	CbGeAlD
Fluvoxamine—SLC6A3—nervous system—Parkinson's disease	0.000321	0.0155	CbGeAlD
Fluvoxamine—SLC6A4—head—Parkinson's disease	0.000311	0.0149	CbGeAlD
Fluvoxamine—SLC6A3—central nervous system—Parkinson's disease	0.000309	0.0149	CbGeAlD
Fluvoxamine—SLC6A3—cerebellum—Parkinson's disease	0.000302	0.0146	CbGeAlD
Fluvoxamine—CYP2B6—cardiovascular system—Parkinson's disease	0.000297	0.0143	CbGeAlD
Fluvoxamine—CYP2C9—cardiovascular system—Parkinson's disease	0.000295	0.0142	CbGeAlD
Fluvoxamine—SLC6A4—nervous system—Parkinson's disease	0.000294	0.0142	CbGeAlD
Fluvoxamine—SLC6A4—central nervous system—Parkinson's disease	0.000283	0.0136	CbGeAlD
Fluvoxamine—CYP2E1—cardiovascular system—Parkinson's disease	0.000279	0.0134	CbGeAlD
Fluvoxamine—SIGMAR1—cerebellum—Parkinson's disease	0.000275	0.0132	CbGeAlD
Fluvoxamine—CYP2D6—brainstem—Parkinson's disease	0.000271	0.013	CbGeAlD
Fluvoxamine—CYP2D6—forebrain—Parkinson's disease	0.000261	0.0126	CbGeAlD
Fluvoxamine—SLC6A3—brain—Parkinson's disease	0.000246	0.0118	CbGeAlD
Fluvoxamine—CYP2E1—medulla oblongata—Parkinson's disease	0.000239	0.0115	CbGeAlD
Fluvoxamine—SLC6A4—brain—Parkinson's disease	0.000225	0.0108	CbGeAlD
Fluvoxamine—SIGMAR1—brain—Parkinson's disease	0.000223	0.0108	CbGeAlD
Fluvoxamine—CYP2E1—spinal cord—Parkinson's disease	0.000213	0.0102	CbGeAlD
Fluvoxamine—ABCB1—embryo—Parkinson's disease	0.000213	0.0102	CbGeAlD
Fluvoxamine—CYP1A1—head—Parkinson's disease	0.000207	0.00998	CbGeAlD
Fluvoxamine—CYP2B6—head—Parkinson's disease	0.000201	0.0097	CbGeAlD
Fluvoxamine—CYP1A1—nervous system—Parkinson's disease	0.000197	0.00946	CbGeAlD
Fluvoxamine—CYP2B6—nervous system—Parkinson's disease	0.000191	0.00919	CbGeAlD
Fluvoxamine—CYP1A1—central nervous system—Parkinson's disease	0.000189	0.00911	CbGeAlD
Fluvoxamine—CYP2E1—head—Parkinson's disease	0.000189	0.0091	CbGeAlD
Fluvoxamine—ABCB1—forebrain—Parkinson's disease	0.000188	0.00905	CbGeAlD
Fluvoxamine—CYP2B6—central nervous system—Parkinson's disease	0.000184	0.00885	CbGeAlD
Fluvoxamine—CYP2E1—nervous system—Parkinson's disease	0.000179	0.00863	CbGeAlD
Fluvoxamine—CYP2E1—central nervous system—Parkinson's disease	0.000173	0.00831	CbGeAlD
Fluvoxamine—CYP2E1—cerebellum—Parkinson's disease	0.000169	0.00812	CbGeAlD
Fluvoxamine—ABCB1—cardiovascular system—Parkinson's disease	0.000159	0.00765	CbGeAlD
Fluvoxamine—CYP1A1—brain—Parkinson's disease	0.00015	0.00723	CbGeAlD
Fluvoxamine—CYP2D6—head—Parkinson's disease	0.00015	0.00721	CbGeAlD
Fluvoxamine—CYP2B6—brain—Parkinson's disease	0.000146	0.00703	CbGeAlD
Fluvoxamine—CYP3A4—nervous system—Parkinson's disease	0.000144	0.00694	CbGeAlD
Fluvoxamine—CYP2D6—nervous system—Parkinson's disease	0.000142	0.00683	CbGeAlD
Fluvoxamine—CYP3A4—central nervous system—Parkinson's disease	0.000139	0.00668	CbGeAlD
Fluvoxamine—CYP2E1—brain—Parkinson's disease	0.000137	0.00659	CbGeAlD
Fluvoxamine—CYP2D6—central nervous system—Parkinson's disease	0.000137	0.00658	CbGeAlD
Fluvoxamine—ABCB1—medulla oblongata—Parkinson's disease	0.000136	0.00654	CbGeAlD
Fluvoxamine—CYP2D6—cerebellum—Parkinson's disease	0.000134	0.00643	CbGeAlD
Fluvoxamine—ABCB1—midbrain—Parkinson's disease	0.000124	0.00598	CbGeAlD
Fluvoxamine—ABCB1—spinal cord—Parkinson's disease	0.000121	0.00583	CbGeAlD
Fluvoxamine—CYP2D6—brain—Parkinson's disease	0.000108	0.00522	CbGeAlD
Fluvoxamine—ABCB1—head—Parkinson's disease	0.000108	0.00518	CbGeAlD
Fluvoxamine—ABCB1—nervous system—Parkinson's disease	0.000102	0.00491	CbGeAlD
Fluvoxamine—ABCB1—central nervous system—Parkinson's disease	9.83e-05	0.00473	CbGeAlD
Fluvoxamine—ABCB1—cerebellum—Parkinson's disease	9.61e-05	0.00462	CbGeAlD
Fluvoxamine—ABCB1—brain—Parkinson's disease	7.8e-05	0.00376	CbGeAlD
Fluvoxamine—CYP1A2—Metabolism—TALDO1—Parkinson's disease	2.33e-05	0.00018	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—OMD—Parkinson's disease	2.33e-05	0.00018	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—DDC—Parkinson's disease	2.29e-05	0.000177	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—DDC—Parkinson's disease	2.28e-05	0.000177	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	2.22e-05	0.000172	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—DBH—Parkinson's disease	2.21e-05	0.000171	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—FBP1—Parkinson's disease	2.21e-05	0.000171	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GBA—Parkinson's disease	2.21e-05	0.000171	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—GSTA4—Parkinson's disease	2.21e-05	0.000171	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	2.21e-05	0.000171	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—DBH—Parkinson's disease	2.19e-05	0.00017	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—FBP1—Parkinson's disease	2.19e-05	0.00017	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GBA—Parkinson's disease	2.19e-05	0.00017	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—GSTA4—Parkinson's disease	2.16e-05	0.000167	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—DDC—Parkinson's disease	2.16e-05	0.000167	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—GSTA4—Parkinson's disease	2.16e-05	0.000167	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GCH1—Parkinson's disease	2.1e-05	0.000163	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	2.1e-05	0.000163	CbGpPWpGaD
Fluvoxamine—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	2.05e-05	0.000159	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GSTA4—Parkinson's disease	2.04e-05	0.000158	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.01e-05	0.000156	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PLA2G6—Parkinson's disease	1.99e-05	0.000154	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—CYP2D6—Parkinson's disease	1.98e-05	0.000153	CbGpPWpGaD
Fluvoxamine—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	1.97e-05	0.000153	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—MAOB—Parkinson's disease	1.97e-05	0.000152	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PLA2G6—Parkinson's disease	1.95e-05	0.000151	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PLA2G6—Parkinson's disease	1.94e-05	0.00015	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—CTGF—Parkinson's disease	1.94e-05	0.00015	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	1.93e-05	0.00015	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—MAOB—Parkinson's disease	1.93e-05	0.000149	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—MAOB—Parkinson's disease	1.92e-05	0.000149	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—MCCC1—Parkinson's disease	1.91e-05	0.000148	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ND3—Parkinson's disease	1.91e-05	0.000148	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	1.9e-05	0.000147	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GBA—Parkinson's disease	1.88e-05	0.000145	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—DBH—Parkinson's disease	1.88e-05	0.000145	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—FBP1—Parkinson's disease	1.88e-05	0.000145	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PLA2G6—Parkinson's disease	1.84e-05	0.000142	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—MAOB—Parkinson's disease	1.82e-05	0.000141	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—CYP2E1—Parkinson's disease	1.81e-05	0.00014	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—OMD—Parkinson's disease	1.8e-05	0.000139	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—TALDO1—Parkinson's disease	1.8e-05	0.000139	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—NQO1—Parkinson's disease	1.79e-05	0.000138	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—DDC—Parkinson's disease	1.77e-05	0.000137	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—TH—Parkinson's disease	1.76e-05	0.000136	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.73e-05	0.000134	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—DDC—Parkinson's disease	1.72e-05	0.000133	CbGpPWpGaD
Fluvoxamine—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	1.71e-05	0.000133	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	1.7e-05	0.000132	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—CYCS—Parkinson's disease	1.69e-05	0.000131	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GSTA4—Parkinson's disease	1.67e-05	0.000129	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.65e-05	0.000127	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GSTA4—Parkinson's disease	1.63e-05	0.000126	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—DDC—Parkinson's disease	1.62e-05	0.000126	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GCH1—Parkinson's disease	1.62e-05	0.000126	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—DDC—Parkinson's disease	1.61e-05	0.000125	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GSTA4—Parkinson's disease	1.53e-05	0.000119	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	1.53e-05	0.000118	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GSTA4—Parkinson's disease	1.52e-05	0.000118	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	1.5e-05	0.000116	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.5e-05	0.000116	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—COMT—Parkinson's disease	1.5e-05	0.000116	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—GSTP1—Parkinson's disease	1.49e-05	0.000115	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—MAOA—Parkinson's disease	1.49e-05	0.000115	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—MAOB—Parkinson's disease	1.49e-05	0.000115	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—HMOX1—Parkinson's disease	1.47e-05	0.000114	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PLA2G6—Parkinson's disease	1.47e-05	0.000113	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CYP2D6—Parkinson's disease	1.46e-05	0.000113	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—MAOB—Parkinson's disease	1.45e-05	0.000112	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—FBP1—Parkinson's disease	1.45e-05	0.000112	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—DBH—Parkinson's disease	1.45e-05	0.000112	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GBA—Parkinson's disease	1.45e-05	0.000112	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CTGF—Parkinson's disease	1.44e-05	0.000111	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CYP2D6—Parkinson's disease	1.43e-05	0.000111	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CYP2D6—Parkinson's disease	1.43e-05	0.000111	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.41e-05	0.00011	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—ABCB1—Parkinson's disease	1.41e-05	0.000109	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CTGF—Parkinson's disease	1.41e-05	0.000109	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CTGF—Parkinson's disease	1.4e-05	0.000109	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	1.38e-05	0.000107	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—DDC—Parkinson's disease	1.38e-05	0.000107	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—GSTM1—Parkinson's disease	1.37e-05	0.000106	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	1.37e-05	0.000106	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—MAOB—Parkinson's disease	1.37e-05	0.000106	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—MAOB—Parkinson's disease	1.36e-05	0.000105	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CYP2D6—Parkinson's disease	1.35e-05	0.000105	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CYP2E1—Parkinson's disease	1.34e-05	0.000104	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CTGF—Parkinson's disease	1.33e-05	0.000103	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—NQO1—Parkinson's disease	1.32e-05	0.000102	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—GPX1—Parkinson's disease	1.31e-05	0.000102	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CYP2E1—Parkinson's disease	1.31e-05	0.000101	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—TH—Parkinson's disease	1.3e-05	0.000101	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GSTA4—Parkinson's disease	1.3e-05	0.000101	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—NQO1—Parkinson's disease	1.3e-05	0.0001	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—NQO1—Parkinson's disease	1.29e-05	0.0001	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.29e-05	9.99e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.28e-05	9.93e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—TH—Parkinson's disease	1.28e-05	9.88e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—TH—Parkinson's disease	1.27e-05	9.86e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CYCS—Parkinson's disease	1.25e-05	9.69e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CYP2E1—Parkinson's disease	1.23e-05	9.56e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CYCS—Parkinson's disease	1.23e-05	9.49e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CYCS—Parkinson's disease	1.22e-05	9.47e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—NQO1—Parkinson's disease	1.22e-05	9.45e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—MTHFR—Parkinson's disease	1.21e-05	9.38e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—TH—Parkinson's disease	1.2e-05	9.32e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	1.17e-05	9.06e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—MAOB—Parkinson's disease	1.16e-05	8.97e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CYCS—Parkinson's disease	1.16e-05	8.94e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—APOE—Parkinson's disease	1.13e-05	8.73e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—COMT—Parkinson's disease	1.11e-05	8.58e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	1.1e-05	8.55e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—GSTP1—Parkinson's disease	1.1e-05	8.54e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.1e-05	8.53e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—MAOA—Parkinson's disease	1.1e-05	8.52e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—HMOX1—Parkinson's disease	1.09e-05	8.42e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—COMT—Parkinson's disease	1.09e-05	8.4e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CTGF—Parkinson's disease	1.08e-05	8.4e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—COMT—Parkinson's disease	1.08e-05	8.38e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—GSTP1—Parkinson's disease	1.08e-05	8.36e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CYP2D6—Parkinson's disease	1.08e-05	8.35e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—GSTP1—Parkinson's disease	1.08e-05	8.35e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—MAOA—Parkinson's disease	1.08e-05	8.34e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—MAOA—Parkinson's disease	1.08e-05	8.33e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—HMOX1—Parkinson's disease	1.07e-05	8.25e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—HMOX1—Parkinson's disease	1.06e-05	8.23e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—DDC—Parkinson's disease	1.06e-05	8.22e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CTGF—Parkinson's disease	1.06e-05	8.19e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ABCB1—Parkinson's disease	1.04e-05	8.08e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—COMT—Parkinson's disease	1.02e-05	7.92e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ABCB1—Parkinson's disease	1.02e-05	7.92e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ABCB1—Parkinson's disease	1.02e-05	7.9e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GSTP1—Parkinson's disease	1.02e-05	7.88e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—MAOA—Parkinson's disease	1.02e-05	7.87e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—GSTM1—Parkinson's disease	1.01e-05	7.85e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	1.01e-05	7.82e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	1.01e-05	7.8e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—HMOX1—Parkinson's disease	1e-05	7.78e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1e-05	7.76e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—NQO1—Parkinson's disease	9.99e-06	7.74e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CTGF—Parkinson's disease	9.98e-06	7.72e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—GSTM1—Parkinson's disease	9.93e-06	7.68e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—GSTM1—Parkinson's disease	9.91e-06	7.67e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CTGF—Parkinson's disease	9.89e-06	7.66e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CYP2E1—Parkinson's disease	9.86e-06	7.64e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—TH—Parkinson's disease	9.85e-06	7.62e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—NQO1—Parkinson's disease	9.75e-06	7.55e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—GPX1—Parkinson's disease	9.71e-06	7.51e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ABCB1—Parkinson's disease	9.64e-06	7.46e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—INS—Parkinson's disease	9.63e-06	7.46e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—TH—Parkinson's disease	9.61e-06	7.44e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—GPX1—Parkinson's disease	9.51e-06	7.36e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—GPX1—Parkinson's disease	9.49e-06	7.34e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CYCS—Parkinson's disease	9.46e-06	7.32e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GSTM1—Parkinson's disease	9.36e-06	7.25e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	9.3e-06	7.2e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CYCS—Parkinson's disease	9.23e-06	7.14e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	9.21e-06	7.13e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—NQO1—Parkinson's disease	9.19e-06	7.11e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—NQO1—Parkinson's disease	9.11e-06	7.05e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—TH—Parkinson's disease	9.06e-06	7.01e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	9.03e-06	6.99e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—TH—Parkinson's disease	8.98e-06	6.95e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GPX1—Parkinson's disease	8.96e-06	6.94e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—MTHFR—Parkinson's disease	8.96e-06	6.93e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—MAOB—Parkinson's disease	8.94e-06	6.92e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—MTHFR—Parkinson's disease	8.77e-06	6.79e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—MTHFR—Parkinson's disease	8.76e-06	6.78e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CYCS—Parkinson's disease	8.7e-06	6.73e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CYCS—Parkinson's disease	8.62e-06	6.67e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	8.61e-06	6.66e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CTGF—Parkinson's disease	8.45e-06	6.54e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—COMT—Parkinson's disease	8.37e-06	6.48e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—APOE—Parkinson's disease	8.34e-06	6.46e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GSTP1—Parkinson's disease	8.33e-06	6.45e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—MAOA—Parkinson's disease	8.31e-06	6.44e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—MTHFR—Parkinson's disease	8.27e-06	6.4e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—HMOX1—Parkinson's disease	8.22e-06	6.36e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—COMT—Parkinson's disease	8.17e-06	6.33e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—APOE—Parkinson's disease	8.17e-06	6.32e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—APOE—Parkinson's disease	8.15e-06	6.31e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GSTP1—Parkinson's disease	8.13e-06	6.3e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—MAOA—Parkinson's disease	8.12e-06	6.28e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—HMOX1—Parkinson's disease	8.02e-06	6.21e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ABCB1—Parkinson's disease	7.89e-06	6.11e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	7.87e-06	6.1e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—NQO1—Parkinson's disease	7.79e-06	6.03e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—COMT—Parkinson's disease	7.7e-06	5.96e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—APOE—Parkinson's disease	7.7e-06	5.96e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—TH—Parkinson's disease	7.67e-06	5.94e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	7.67e-06	5.93e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GSTM1—Parkinson's disease	7.66e-06	5.93e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—MAOA—Parkinson's disease	7.65e-06	5.92e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—COMT—Parkinson's disease	7.64e-06	5.91e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GSTP1—Parkinson's disease	7.6e-06	5.88e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—MAOA—Parkinson's disease	7.58e-06	5.87e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	7.56e-06	5.85e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—HMOX1—Parkinson's disease	7.49e-06	5.8e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GSTM1—Parkinson's disease	7.48e-06	5.79e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYCS—Parkinson's disease	7.37e-06	5.7e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GPX1—Parkinson's disease	7.33e-06	5.68e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	7.26e-06	5.62e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ABCB1—Parkinson's disease	7.19e-06	5.57e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GPX1—Parkinson's disease	7.16e-06	5.54e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—INS—Parkinson's disease	7.12e-06	5.51e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	7.04e-06	5.45e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GSTM1—Parkinson's disease	6.98e-06	5.41e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—INS—Parkinson's disease	6.98e-06	5.4e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—INS—Parkinson's disease	6.96e-06	5.39e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—MTHFR—Parkinson's disease	6.77e-06	5.24e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GPX1—Parkinson's disease	6.75e-06	5.22e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GPX1—Parkinson's disease	6.69e-06	5.18e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	6.64e-06	5.14e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—MTHFR—Parkinson's disease	6.61e-06	5.11e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—INS—Parkinson's disease	6.58e-06	5.09e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—COMT—Parkinson's disease	6.52e-06	5.05e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CTGF—Parkinson's disease	6.52e-06	5.05e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GSTP1—Parkinson's disease	6.49e-06	5.03e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—MAOA—Parkinson's disease	6.48e-06	5.02e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—HMOX1—Parkinson's disease	6.4e-06	4.96e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—APOE—Parkinson's disease	6.3e-06	4.88e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	6.23e-06	4.82e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—MTHFR—Parkinson's disease	6.17e-06	4.78e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—APOE—Parkinson's disease	6.15e-06	4.76e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ABCB1—Parkinson's disease	6.15e-06	4.76e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	6.08e-06	4.7e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NQO1—Parkinson's disease	6.01e-06	4.65e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GSTM1—Parkinson's disease	5.97e-06	4.62e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—TH—Parkinson's disease	5.92e-06	4.58e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—APOE—Parkinson's disease	5.8e-06	4.49e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—APOE—Parkinson's disease	5.75e-06	4.45e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GPX1—Parkinson's disease	5.71e-06	4.42e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYCS—Parkinson's disease	5.69e-06	4.4e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—INS—Parkinson's disease	5.38e-06	4.17e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—MTHFR—Parkinson's disease	5.27e-06	4.08e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—INS—Parkinson's disease	5.25e-06	4.07e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—COMT—Parkinson's disease	5.04e-06	3.9e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GSTP1—Parkinson's disease	5.01e-06	3.88e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—MAOA—Parkinson's disease	5e-06	3.87e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—INS—Parkinson's disease	4.95e-06	3.83e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—HMOX1—Parkinson's disease	4.94e-06	3.83e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—APOE—Parkinson's disease	4.91e-06	3.8e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—INS—Parkinson's disease	4.91e-06	3.8e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ABCB1—Parkinson's disease	4.74e-06	3.67e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GSTM1—Parkinson's disease	4.61e-06	3.57e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GPX1—Parkinson's disease	4.41e-06	3.41e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—INS—Parkinson's disease	4.19e-06	3.25e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—MTHFR—Parkinson's disease	4.07e-06	3.15e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—APOE—Parkinson's disease	3.79e-06	2.93e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—INS—Parkinson's disease	3.24e-06	2.51e-05	CbGpPWpGaD
